Objective To identify the most robust molecular biomarkers in sperm and seminal plasma for
the diagnosis of male infertility, and to evaluate their clinical use. Design Systematic review …

Seminal plasma is a complex fluid comprised of secretions from the seminal vesicles, the
prostate, bulbourethral glands and from the seminiferous tubule lumen/epididymides/vasa …

Current design of serological tests utilizes conservative immunoassay approaches and is
focused on fast and convenient assay development, throughput, straightforward …

The compounds of seminal plasma have great potential as biomarkers of male fertility and
can be used as a diagnostic tool for types of azoospermia. Azoospermia occurs in …

Infertility affects 1 in 6 couples, and male factor infertility has been implicated as a cause in
50% of cases. Azoospermia is defined as the absence of spermatozoa in the ejaculate and …

Infertility affects a significant proportion of the reproductive‐aged population, with male‐
associated factors contributing to over half of the cases. However, current diagnostic tools …

Serological diagnostics is generally defined as the detection of specific human
immunoglobulins developed against viral, bacterial, or parasitic diseases. Serological tests …

Understanding molecular mechanisms that underpin azoospermia and discovery of
biomarkers that could enable reliable, non-invasive diagnosis are highly needed. Using …

Male infertility is a commonly encountered pathology that is estimated to be a contributory
factor in approximately 50% of couples seeking recourse to assisted reproductive …

Male infertility has emerged as an important cause of infertility worldwide. There are many
factors affecting male fertility and research is going on to know impact of various factors on …